Healthcare • Drug Manufacturers - Specialty & Generic
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if SUPN is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
35 top institutions tracked
Last 13F trend: accumulating (heavy)
Unlock crowding heatmapUnlock filer discoverySentiment: unknown
No recent insider trades detected.
Red flags: 1
333 filers reported a long position in SUPN for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| BlackRock, Inc. | $434.9M | 9.4M | +6.3% |
| MILLENNIUM MANAGEMENT LLC | $179.2M | 3.9M | +16.2% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $153.7M | 3.3M | +2.1% |
| ARMISTICE CAPITAL, LLC | $123.1M | 2.6M | +39.6% |
| VANGUARD CAPITAL MANAGEMENT LLC | $117.1M | 2.5M | +2% |
| STATE STREET CORP | $114.4M | 2.5M | +7.5% |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $110.6M | 2.4M | +16.7% |
| DIMENSIONAL FUND ADVISORS LP | $96.7M | 2.1M | -9.9% |
| GEODE CAPITAL MANAGEMENT, LLC | $73M | 1.6M | -3.3% |
| Stephens Investment Management Group LLC | $69.1M | 1.5M | +10% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.